Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Cardiologist agrees to pay $5M | Key advances in STEMI care, drug delivery | Severe TR in high-risk HF patients
Friday, June 16, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Cardiologist agrees to pay $5M for overstating heart findings to justify unnecessary procedures

The North Carolina physician allegedly performed unnecessary atherectomy procedures to treat minor blockages in the leg arteries of multiple patients.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist agrees to pay $5M for overstating heart findings to justify unnecessary procedures

Share on Twitter Share on Facebook Share on Linkedin
The North Carolina physician allegedly performed unnecessary atherectomy procedures to treat minor blockages in the leg arteries of multiple patients.
READ MORE >

Cardiac ultrasound could lead to key advances in heart attack care, drug delivery

Jonathan Lindner, MD, offers an update on the use of echocardiography and bubble contrast agents in a therapy role to help revascularize STEMI patients and increase drug and gene delivery.

READ MORE >
Video of Jon Lindner explaining the use of ultrasound and bubble contrast for therapy.
Share on Twitter Share on Facebook Share on Linkedin

Cardiac ultrasound could lead to key advances in heart attack care, drug delivery

Share on Twitter Share on Facebook Share on Linkedin
Video of Jon Lindner explaining the use of ultrasound and bubble contrast for therapy.
Jonathan Lindner, MD, offers an update on the use of echocardiography and bubble contrast agents in a therapy role to help revascularize STEMI patients and increase drug and gene delivery.
READ MORE >

Cardiologists shed new light on treating severe tricuspid regurgitation in high-risk heart failure patients

The 80-year-old patient was experiencing severe TR and already had a HeartMate II LVAD. 

READ MORE >
TricValve Transcatheter Bicaval Valves System and HeartMate II LVAD. A team of interventional cardiologists has made a bit of history, using a new transcatheter device to treat tricuspid regurgitation (TR) in a high-risk heart failure patient who with a previously implanted left ventricular assist device (LVAD). It represents the first time this particular device, the TricValve Transcatheter Bicaval Valves System from P+F Products, has been implanted in a patient with this particular LVAD, the HeartMate II.
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists shed new light on treating severe tricuspid regurgitation in high-risk heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
TricValve Transcatheter Bicaval Valves System and HeartMate II LVAD. A team of interventional cardiologists has made a bit of history, using a new transcatheter device to treat tricuspid regurgitation (TR) in a high-risk heart failure patient who with a previously implanted left ventricular assist device (LVAD). It represents the first time this particular device, the TricValve Transcatheter Bicaval Valves System from P+F Products, has been implanted in a patient with this particular LVAD, the HeartMate II.
The 80-year-old patient was experiencing severe TR and already had a HeartMate II LVAD. 
READ MORE >

Featured Articles

How a New Hampshire heart surgeon racked up 21 malpractice settlements

A law firm hired to investigate the situation reviewed more than 300,000 pages of documents and conducted more than 250 hours of interviews. 

READ MORE >
medical_malpractice_08.jpg
Share on Twitter Share on Facebook Share on Linkedin

How a New Hampshire heart surgeon racked up 21 malpractice settlements

Share on Twitter Share on Facebook Share on Linkedin
medical_malpractice_08.jpg
A law firm hired to investigate the situation reviewed more than 300,000 pages of documents and conducted more than 250 hours of interviews. 
READ MORE >

FDA clears new ‘grab-and-go’ interventional device for below-the-knee blood clot removal

The new device was designed to remove thrombi and emboli from peripheral arteries ranging from 2 to 4 mm. 

READ MORE >
The Pounce Thrombectomy System by Surmodics. The company just gained FDA clearance on a new version of the system for smaller arteries. 
Share on Twitter Share on Facebook Share on Linkedin

FDA clears new ‘grab-and-go’ interventional device for below-the-knee blood clot removal

Share on Twitter Share on Facebook Share on Linkedin
The Pounce Thrombectomy System by Surmodics. The company just gained FDA clearance on a new version of the system for smaller arteries. 
The new device was designed to remove thrombi and emboli from peripheral arteries ranging from 2 to 4 mm. 
READ MORE >

Mitral valve repair: How a minimally invasive approach compares to conventional surgery

Researchers compared minithoracotomy, a minimally invasive procedure for treating degenerative mitral regurgitation, with conventional surgery, sharing their findings in JAMA. The research was previously presented as a late-breaking study at ACC.23. 

READ MORE >
surgery.jpg
Share on Twitter Share on Facebook Share on Linkedin

Mitral valve repair: How a minimally invasive approach compares to conventional surgery

Share on Twitter Share on Facebook Share on Linkedin
surgery.jpg
Researchers compared minithoracotomy, a minimally invasive procedure for treating degenerative mitral regurgitation, with conventional surgery, sharing their findings in JAMA. The research was previously presented as a late-breaking study at ACC.23. 
READ MORE >

In Case You Missed It

Nearing a ‘breaking point’: Cardiologists support legislation designed to mitigate Medicare cuts to office-based services

These latest cuts could be a "breaking point" for physicians, according to a new letter to lawmakers. 

READ MORE >
Medicare money payment
Share on Twitter Share on Facebook Share on Linkedin

Nearing a ‘breaking point’: Cardiologists support legislation designed to mitigate Medicare cuts to office-based services

Share on Twitter Share on Facebook Share on Linkedin
Medicare money payment
These latest cuts could be a "breaking point" for physicians, according to a new letter to lawmakers. 
READ MORE >

VIDEO: Jagmeet Singh details the SOLVE-CRT study for a leadless CRT system

Findings from the SOLVE-CRT study were presented to attendees at Heart Rhythm 2023. "Our results showed the study was safe, effective and feasible," Singh said. 

READ MORE >
Jagmeet Singh, MD, explains details of the SOLVE-CRT pivotal clinical trial at HRS 2023. #HRS #HRS2023
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Jagmeet Singh details the SOLVE-CRT study for a leadless CRT system

Share on Twitter Share on Facebook Share on Linkedin
Jagmeet Singh, MD, explains details of the SOLVE-CRT pivotal clinical trial at HRS 2023. #HRS #HRS2023
Findings from the SOLVE-CRT study were presented to attendees at Heart Rhythm 2023. "Our results showed the study was safe, effective and feasible," Singh said. 
READ MORE >

In Other News

Implementing point-of-care AI? 5 firm facts to keep in mind

If healthcare AI is to flourish outside of academic research settings and industry R&D departments, it will need to win over its most difficult-to-impress audience: healthcare workers in hospitals.

READ MORE >
artificial intelligence hospital patients
Share on Twitter Share on Facebook Share on Linkedin

Implementing point-of-care AI? 5 firm facts to keep in mind

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence hospital patients
If healthcare AI is to flourish outside of academic research settings and industry R&D departments, it will need to win over its most difficult-to-impress audience: healthcare workers in hospitals.
READ MORE >

Continued declines in screening mammogram volumes could have 'worrisome implications,' experts warn

The downward trend is most notable in women who have at least one risk factor of severe COVID, new data suggest.

READ MORE >
mammogram mammography breast cancer
Share on Twitter Share on Facebook Share on Linkedin

Continued declines in screening mammogram volumes could have 'worrisome implications,' experts warn

Share on Twitter Share on Facebook Share on Linkedin
mammogram mammography breast cancer
The downward trend is most notable in women who have at least one risk factor of severe COVID, new data suggest.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup